Testing effectiveness (Phase 2)Study completedNCT02494570What this trial is testingNab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComaWho this might be right forMalignant PEComa Aadi Bioscience, Inc. 34
Testing effectiveness (Phase 2)Looking for participantsNCT06683846What this trial is testingIvonescimab in the Treatment of Multiple Advanced TumorsWho this might be right forPheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more Fudan University 400
Early research (Phase 1)Ended earlyNCT01552434What this trial is testingBevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseWho this might be right forAdvanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)UnknownNCT05625919What this trial is testingSafety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)Who this might be right forAdvanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 54
Not applicableApproved For MarketingNCT03817515What this trial is testingExpanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway ActivationWho this might be right forPEComa, MalignantTSC1TSC2+1 more Aadi Bioscience, Inc.